Ding X, Saxena NK, Lin S, Gupta NA, Gupta N, Anania FA Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
[13] Treatment was given for 104 weeks (2 years), and the occurrence of cardiovascular events, including heart attacks, strokes, and hospitalization due to unstable angina (near heart attack) were recorded and compared in the two groups of participants
This medication contains liraglutide, which can affect the growth of unborn babies and may cause harm to newborns
Microbiome-based interventions for skin aging and barrier function: a comprehensive review
This article explains the science, the best food choices, realistic expectations, and practical steps you can take now
Powered by Froala Editor In case of Overdose Seek Immediate Medical Attention : Contact a healthcare provider or go to the nearest emergency room